Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy. Part I. Procedural aspects, diagnosticadequacy, and accuracy

Radiology

Volumn 265, Issue 3, 2012, Pages 819-831

  Howlett, David C ^a   Drinkwater, Karl J ^b   Lawrence, David ^c   Barter, Susan ^d   Nicholson, Tony ^e  

^a EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^b ROYAL COLLEGE OF RADIOLOGISTS   (United Kingdom)

^c NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANALYTICAL PARAMETERS; ARTICLE; BIOPSY TECHNIQUE; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FALSE NEGATIVE RESULT; HUMAN; HUMAN TISSUE; INSTITUTIONAL REVIEW; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL DOCUMENTATION; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY CONTROL; RADIOLOGIST; RADIOLOGY; RETROSPECTIVE STUDY; SAMPLING; SENSITIVITY AND SPECIFICITY; TISSUE SECTION; UNITED KINGDOM;

BIOPSY; CHI-SQUARE DISTRIBUTION; GREAT BRITAIN; HUMANS; LIVER DISEASES; LOGISTIC MODELS; MEDICAL AUDIT; QUESTIONNAIRES; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84870025608     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12111562     Document Type: Article

References (31)

1. Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134(1):8-14. (Pubitemid 350309358)
2. Al Knawy B, Shiffman M. Percutaneous liver biopsy in clinical practice. Liver Int2007;27(9):1166-1173. (Pubitemid 47543144)
3. Malnick S, Melzer E. Routine ultrasound-guided liver biopsy: a time whose idea has come? J Clin Gastroenterol 2005;39(10):900-903. (Pubitemid 41504672)
4. Syn WK, Bruckner-Holt C, Farmer A, Howdle S, Bateman J. Liver biopsy in a district general hospital: changes over two decades. World J Gastroenterol 2007;13(40):5336-5342. (Pubitemid 47559464)
5. Stattaus J, Kuehl H, Ladd S, et al. CT-guided biopsy of small liver lesions: visibility, artifacts, and corresponding diagnostic accuracy. Cardiovasc Intervent Radiol 2007;30(5):928-935. (Pubitemid 47497840)
6. Schmidt AJ, Kee ST, Sze DY, et al. Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies. J Vasc Interv Radiol 1999;10(10):1323-1329.
7. Neuberger J, Grant A, Day C, Saxseena S. Guidelines for the use of liver biopsy in clinical practice. London, England: British Society of Gastroenterology, 2004; 1-15.
8. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009;49(3):1017-1044.
9. Howlett DC, Drinkwater KJ, Lawrence D, Barter S, Nicholson T. Findings of the UK national audit evaluating image-guided or assisted liver biopsy. I. Minor and major complications and procedur- related mortality. Radiology (in press).
10. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009;360(5):491-499.
11. The Royal College of Radiologists. Standards for the National Patient Safety Association and Royal College of Radiologists safety checklist for radiological interventions. London, England: The Royal College of Radiologists, 2010.
12. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344(7):495-500. (Pubitemid 32164902)
13. Cholongitas E, Senzolo M, Standish RA, et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol 2006;125(5):710-721.
14. Nazarian LN, Feld RI, Herrine SK, et al. Safety and efficacy of sonographically guided random core biopsy for diffuse liver disease. J Ultrasound Med 2000;19(8):537-541.
15. Farrell RJ, Smiddy PF, Pilkington RM, et al. Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol 1999;30(4):580-587. (Pubitemid 29151898)
16. Choo L, Zekry A, Freiman J. Percutaneous liver biopsy by prior ultrasound marking versus direct ultrasound guidance: complications and adequacy. Gastroenterol Hepatol 2009;24(suppl 2):A294-A295.
17. Padia SA, Baker ME, Schaeffer CJ, et al. Safety and efficacy of sonographic-guided random real-time core needle biopsy of the liver. Clin Ultrasound 2009;37(3):138-143.
18. Francque SM, De Pauw FF, Van den Steen GH, Van Marck EA, Pelckmans PA, Michielsen PP. Biopsy of focal liver lesions: guidelines, comparison of techniques and cost-analysis. Acta Gastroenterol Belg 2003;66(2):160-165. (Pubitemid 36828089)
19. Sparchez Z, Radu P, Zaharia T, et al. Usefulness of contrast enhanced ultrasound guidance in percutaneous biopsies of liver tumors. J Gastrointestin Liver Dis 2011;20(2):191-196.
20. Buscarini L, Fornari F, Bolondi L, et al. Ultrasound-guided fine-needle biopsy of focal liver lesions: techniques, diagnostic accuracy and complications: a retrospective study on 2091 biopsies. J Hepatol 1990;11(3):344-348.
21. Appelbaum L, Kane RA, Kruskal JB, Romero J, Sosna J. Focal hepatic lesions: US guided biopsy-lessons from review of cytologic and pathologic examination results. Radiology 2009;250(2):453-458.
22. Caturelli E, Solmi L, Anti M, et al. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 2004;53(9):1356-1362. (Pubitemid 39120127)
23. Nyman RS, Cappelen-Smith J, Brismar J, von Sinner W, Kagevi I. Yield and complications in ultrasound-guided biopsy of abdominal lesions: comparison of fine-needle aspiration biopsy and 1.2-mm needle core biopsy using an automated biopsy gun. Acta Radiol 1995;36(5):485-490.
24. Schmidt AJ, Kee ST, Sze DY, et al. Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies. J Vasc Interv Radiol 1999;10(10): 1323-1329.
25. Mohammed MA. Using statistical process control to improve the quality of health care. Qual Saf Health Care 2004;13(4):243-245. (Pubitemid 39070887)
26. Mohammed MA, Cheng KK, Rouse A, Marshall T. Bristol, Shipman, and clinical governance: Shewhart's forgotten lessons. Lancet 2001;357(9254):463- 467. (Pubitemid 32156152)
27. Garcia-Tsao G, Boyer JL. Outpatient liver biopsy: how safe is it? Ann Intern Med 1993;118(2):150-153.
28. Röcken C, Meier H, Klauck S, Wolff S, Malfertheiner P, Roessner A. Large-needle biopsy versus thin-needle biopsy in diagnostic pathology of liver diseases. Liver 2001;21(6):391-397. (Pubitemid 33095042)
29. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128(7):1898-1906. (Pubitemid 40824701)
30. Barter S, Drinkwater K, Remedios D. National audit of provision of MRI services 2006/07. Clin Radiol 2009;64(3):284-290.
31. Chalmers N, Jones K, Drinkwater K, Uberoi R, Tawn J. The UK nephrostomy audit: can a voluntary registry produce robust performance data? Clin Radiol 2008;63(8):888-894.